MDxHealth SA
General ticker "MDXH" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $101.0M
MDxHealth SA does not follow the US Stock Market performance with the rate: -33.3%.
Estimated limits based on current volatility of 6.1%: low 2.04$, high 2.30$
Factors to consider:
- Current price 16.5% below estimated low
- Earnings for 9 months up through Q3 are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2023-12-31 to 2025-12-30
- 2023-12-31 to 2024-12-30 estimated range: [2.60$, 5.85$]
- 2024-12-30 to 2025-12-30 estimated range: [2.84$, 6.23$]
Financial Metrics affecting the MDXH estimates:
- Negative: Non-GAAP EPS, $ of -1.14 <= 0.10
- Negative: Operating profit margin, % of -28.02 <= 1.03
- Negative: Operating cash flow per share per price, % of -20.44 <= 2.35
- Negative: negative Net income
- Positive: -0.96 < Investing cash flow per share, $ of -0.15
- Negative: Industry operating cash flow per share per price (median), % of -23.87 <= 3.85
Short-term MDXH quotes
Long-term MDXH plot with estimates
Financial data
| YTD | 2021-12-31 | 2022-12-31 | 2023-12-31 |
|---|---|---|---|
| Operating Revenue | $22.24MM | $37.05MM | $70.19MM |
| Operating Expenses | $49.08MM | $74.95MM | $97.52MM |
| Operating Income | $-26.84MM | $-37.90MM | $-27.33MM |
| Non-Operating Income | $-2.16MM | $-6.14MM | $-15.77MM |
| Interest Expense | $1.88MM | $6.14MM | $5.58MM |
| R&D Expense | $6.67MM | $7.56MM | $6.38MM |
| Income(Loss) | $-29.00MM | $-44.04MM | $-43.10MM |
| Taxes | $1.88MM | $6.14MM | $0.00MM |
| Profit(Loss) | $-30.88MM | $-50.19MM | $-43.10MM |
| Stockholders Equity | $46.90MM | $9.31MM | $7.21MM |
| Inventory | $1.91MM | $2.33MM | $2.78MM |
| Assets | $75.07MM | $119.14MM | $129.13MM |
| Operating Cash Flow | $-22.55MM | $-34.12MM | $-21.50MM |
| Capital expenditure | $0.90MM | $4.16MM | $5.02MM |
| Investing Cash Flow | $-0.89MM | $-29.16MM | $-3.93MM |
| Financing Cash Flow | $66.50MM | $20.84MM | $32.28MM |
| Earnings Per Share* | $-2.53 | $-3.16 | $-1.66 |
* EPS are Split Adjusted, recent splits may be reflected with a delay.